Friday, November 9, 2012

Zimmer tallies remaining legal costs for temporarily recalled Durom MoM hips at nearly $230M

November 8, 2012 by MassDevice staff

Orthopedic giant Zimmer expects another $230 million in legal costs for its Durom metal-on-metal acetabular hip implants, which were pulled off of shelves for about 1 month in 2008.
Corrected November 9, 2012, at 3:45 p.m.
Orthopedic devices maker Zimmer Holdings (NYSE:ZMH) expects to pay another $229.7 million to handle legal complaints spurred by the temporary 2008 recall of its Durom metal-on-metal acetabular hip components, according to the company's latest earnings release.

Zimmer in 2008 pulled the devices off of shelves for a period of about 1 month while it investigated "certain reports of an unusually high rate of revision," according to regulatory filings from the time.
The company ultimately attributed device failures to improper implantation techniques and restored the devices to the market, but not without garnering some unwanted legal attention


  November 1.2012   Zimmer pulls metal-on-metal Durom acetabular hip implants from Australian market

Orthopedic devices giant Zimmer cancels its Durom acetabular hip implant component from the Australian market amid higher revision rates.
In another blow to the metal-on-metal hip implant market, orthopedic giant Zimmer Holdings (NYSE:ZMH) canceled its Durom Acetabular Component from the Australian Register of Therapeutic Goods, the regulatory agency announced this week.

No comments:

Post a Comment